|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/13/21 Biolase, Inc. 10-Q 3/31/21 81:9.4M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 900K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
3: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
10: R1 Document and Entity Information HTML 77K
11: R2 Consolidated Balance Sheets (Unaudited) HTML 115K
12: R3 Consolidated Balance Sheets (Unaudited) HTML 54K
(Parenthetical)
13: R4 Consolidated Statements Of Operations And HTML 108K
Comprehensive Loss (Unaudited)
14: R5 Consolidated Statements Of Redeemable Preferred HTML 87K
Stock and Stockholders' Equity (Unaudited)
15: R6 Consolidated Statements Of Cash Flows (Unaudited) HTML 108K
16: R7 Description of Business and Basis of Presentation HTML 35K
17: R8 Summary of Significant Accounting Policies HTML 37K
18: R9 Revenue Recognition HTML 105K
19: R10 Redeemable Preferred Stock and Stockholders' HTML 225K
Equity
20: R11 Inventory HTML 41K
21: R12 Property, Plant, and Equipment HTML 59K
22: R13 Intangible Assets and Goodwill HTML 27K
23: R14 Accrued Liabilities HTML 81K
24: R15 Debt HTML 111K
25: R16 Leases HTML 85K
26: R17 Commitments and Contingencies HTML 33K
27: R18 Segment Information HTML 59K
28: R19 Concentrations HTML 64K
29: R20 Income Taxes HTML 31K
30: R21 Subsequent Events HTML 25K
31: R22 Summary of Significant Accounting Policies HTML 127K
(Policies)
32: R23 Revenue Recognition (Tables) HTML 93K
33: R24 Redeemable Preferred Stock and Stockholders' HTML 213K
Equity (Tables)
34: R25 Inventory (Tables) HTML 41K
35: R26 Property, Plant, and Equipment (Tables) HTML 57K
36: R27 Accrued Liabilities (Tables) HTML 79K
37: R28 Debt (Tables) HTML 79K
38: R29 Leases (Tables) HTML 82K
39: R30 Segment Information (Tables) HTML 55K
40: R31 Concentrations (Tables) HTML 62K
41: R32 Description of Business and Basis of Presentation HTML 41K
- Additional Information (Detail)
42: R33 Revenue Recognition - Additional Information HTML 33K
(Detail)
43: R34 Summary of Opening and Closing Balances of HTML 33K
Contract Liabilities (Detail)
44: R35 Summary of Disaggregation of Revenues Related to HTML 32K
Geographic Areas (Detail)
45: R36 Summary of Revenues Disaggregated by Timing of HTML 32K
Goods and Services Transferred (Detail)
46: R37 Summary of Sales by End Market (Detail) HTML 32K
47: R38 Redeemable Preferred Stock and Stockholders' HTML 162K
Equity - Additional Information (Detail)
48: R39 Classification of Compensation Expense Associated HTML 34K
with Share-Based Payments (Detail)
49: R40 Assumptions Used in Estimating Fair Value of Stock HTML 30K
Options Granted (Detail)
50: R41 Summary of Option Activity (Detail) HTML 53K
51: R42 Summary of Unvested Stock Option Activity (Detail) HTML 38K
52: R43 Cash Proceeds Along with Fair Value Disclosures HTML 32K
Related to Grants, Exercises and Vested Options
(Detail)
53: R44 Summary of Unvested Restricted Stock Units HTML 44K
(Detail)
54: R45 Summary of Warrant Activity (Detail) HTML 38K
55: R46 Components of Inventory (Detail) HTML 31K
56: R47 Inventory - Additional Information (Detail) HTML 24K
57: R48 Summary of Property, Plant, and Equipment (Detail) HTML 45K
58: R49 Property, Plant, and Equipment - Additional HTML 24K
Information (Detail)
59: R50 Intangible Assets and Goodwill - Additional HTML 30K
Information (Detail)
60: R51 Components of Accrued Liabilities (Detail) HTML 45K
61: R52 Changes in Initial Product Warranty Accrual and HTML 36K
Expenses Under Initial and Extended Warranties
(Detail)
62: R53 Accrued Liabilities - Additional Information HTML 34K
(Detail)
63: R54 Debt - Summary of Principal Outstanding and HTML 38K
Unamortized Discount (Detail)
64: R55 Debt - Additional Information (Detail) HTML 263K
65: R56 Debt - Summary of Future Minimum Principal and HTML 54K
Interest Payments (Detail)
66: R57 Leases - Additional Information (Detail) HTML 62K
67: R58 Leases - Information related to Right-of-use HTML 31K
Assets and Liabilities (Detail)
68: R59 Leases - Schedule of Maturities of Lease HTML 43K
Liabilities (Detail)
69: R60 Leases - Future Minimum Rental Commitments Under HTML 41K
Lease Agreements (Detail)
70: R61 Commitments and Contingencies - Additional HTML 52K
Information (Detail)
71: R62 Segment Information - Additional Information HTML 35K
(Detail)
72: R63 Summary of Net Revenue by Geographic Location HTML 32K
(Detail)
73: R64 Summary of Property, Plant and Equipment by HTML 29K
Geographic Location (Detail)
74: R65 Concentrations - Summary of Net Revenue from HTML 49K
Various Products (Detail)
75: R66 Concentrations - Additional Information (Detail) HTML 37K
76: R67 Income Taxes - Additional Information (Detail) HTML 33K
77: R68 Subsequent Events - Additional Information HTML 28K
(Detail)
79: XML IDEA XML File -- Filing Summary XML 149K
9: XML XBRL Instance -- biol-20210331_htm XML 2.13M
78: EXCEL IDEA Workbook of Financial Reports XLSX 101K
8: EX-101.CAL XBRL Calculations -- biol-20210331_cal XML 172K
5: EX-101.DEF XBRL Definitions -- biol-20210331_def XML 686K
7: EX-101.LAB XBRL Labels -- biol-20210331_lab XML 1.63M
4: EX-101.PRE XBRL Presentations -- biol-20210331_pre XML 1.15M
6: EX-101.SCH XBRL Schema -- biol-20210331 XSD 236K
80: JSON XBRL Instance as JSON Data -- MetaLinks 420± 654K
81: ZIP XBRL Zipped Folder -- 0000950170-21-000226-xbrl Zip 236K
| EX-32.1 |
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. § 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of BIOLASE, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2021 (the “Report”), I, John R. Beaver, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 13, 2021 |
|
By: |
/s/ JOHN R. BEAVER |
|
|
|
|
|
|
|
President and Chief Executive Officer (Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/13/21 | 8-K, DEFA14A | ||
| For Period end: | 3/31/21 | 10-K | ||
| List all Filings | ||||